Phase 3 randomized double-blind placebo-controlled study of intradetrusor BOTOX in idiopathic overactive bladder with urinary incontinence

Phase 3, randomised, double-blind trial in overactive bladder (OAB) and urinary incontinence (UI) comparing BOTOX 100 U with Placebo (2 arms). Primary endpoints: Number of episodes of urinary incontinence and Positive response on Treatment Benefit Scale. Started Jul 2010; status: active, not recruiting.